COMP <GO>
RVP vs PMI // EV/EBITDA & P/E VALUATION
Retractable Technologies Inc. (NYSE) VS. Picard Medical Inc. (NYSE) • 15-METRIC TALLY: RVP 0
— PMI 2
■ METRIC PARITY
LAST: $0.58 (-1.15%) • MKT CAP: $17.3M
valuation
—
LAST: $8.11 (+12.17%) • MKT CAP: $19.9M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RVP VS. PMI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RVP | PMI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 0.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -23.30% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -55.30% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -32.80% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 15.80% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.52 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 22.7 | 50.2 | -27.51 | PMI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $17.3M | $19.9M | -$2.7M | PMI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RVP REV | PMI REV | RVP GROSS % | PMI GROSS % | RVP FCF | PMI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $38.3M | $0 | 0.1% | — | -$7.1M | — |
| FY 2024 | $33.0M | — | -3.1% | — | -$13.0M | — |
| FY 2023 | $43.6M | — | — | — | $2.8M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RVP // BETA —
PMI // BETA —